SCHEMBL6957010

SCHEMBL6957010

CCCC1(CCc2ccc(F)cc2)CC(O)=C(C(c2cccc(NC(=O)OCc3ccccc3)c2)C(C)(C)C)C(=O)O1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.48
MLNR O43193 1/20 0.48
NR1I2 O75469 1/20 0.48
ABCB11 O95342 1/20 0.48
PGR P06401 1/20 0.48
CTSD P07339 1/20 0.48
CHRM2 P08172 1/20 0.48
ADRA2A P08913 1/20 0.48
PGA5 P0DJD9 1/20 0.48
ADORA3 P0DMS8 1/20 0.48
CTSE P14091 1/20 0.48
GABRA1 P14867 1/20 0.48
ADRA2C P18825 1/20 0.48
DRD1 P21728 1/20 0.48
HTR2A P28223 1/20 0.48
AGTR1 P30556 1/20 0.48
CCKAR P32238 1/20 0.48
ADRA1A P35348 1/20 0.48
PTGS2 P35354 1/20 0.48
OPRD1 P41143 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7400242 0.97 MGLL (0.45) PPARGMLNRNR1I2ABCB11PGR
SCHEMBL7400987 0.86 MLNR (0.54) PPARGMLNRNR1I2ABCB11PGR
SCHEMBL8806637 0.83 MGLL (0.45) PPARGMLNRNR1I2ABCB11PGR
SCHEMBL6959300 0.81 MLNR (0.44) PPARGMLNRNR1I2ABCB11PGR
SCHEMBL8808931 0.81 MGLL (0.47) PPARGMLNRNR1I2ABCB11PGR
SCHEMBL7401486 0.81 MLNR (0.45) PPARGMLNRNR1I2ABCB11PGR
SCHEMBL7403297 0.78 MLNR (0.40) PPARGMLNRNR1I2ABCB11PGR
SCHEMBL7398797 0.77 MLNR (0.52) PPARGMLNRNR1I2ABCB11PGR
SCHEMBL7397907 0.77 MLNR (0.64) PPARGMLNRNR1I2ABCB11PGR
SCHEMBL7395259 0.77 MLNR (0.64) PPARGMLNRNR1I2ABCB11PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0758327-B1 PYRANONE COMPOUNDS USEFUL TO TREAT RETROVIRAL INFECTIONS UPJOHN CO (US) 2003-04-09 EP disclosed
US-6169181-B1 HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITORS PHARMACIA & UPJOHN COMPANY 2001-01-02 US disclosed
US-5852195-A Pyranone compounds useful to treat retroviral infections PHARMACIA & UPJOHN COMPANY (US) 1998-12-22 US disclosed
EP-0783505-A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE Novartis AG (CH) 1997-07-16 EP disclosed
EP-0758327-A1 PYRANONE COMPOUNDS USEFUL TO TREAT RETROVIRAL INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 1997-02-19 EP disclosed
WO-1996010028-A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE NOVARTIS AG (CH) 1996-04-04 WO disclosed
WO-1995030670-A2 PYRANONE COMPOUNDS USEFUL TO TREAT RETROVIRAL INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 1995-11-16 WO disclosed